ADHD diagnostic assessment, prescribing & titration

The procurement process for an ADHD diagnostic assessment, prescribing, and titration service in Kent & Medway has reached the award stage. The contract has been awarded by NHS Kent and Medway Integrated Care Board, located in Maidstone, UK. This process is part of the Health Care Services (Provider Selection Regime) Regulations 2023, and does not fall under the Procurement Act 2023.

The contract was awarded through a limited procurement method without prior publication of a call for competition. The contract period extends from 1st April 2025 to 31st March 2028, with an option to extend for a further 12 months. This tender offers business growth opportunities particularly for small and medium-sized enterprises (SMEs) specialising in health services.

Given its nature, companies that provide comprehensive ADHD assessment and treatment services would be well-suited to compete. Although the contract uses an existing supplier, the opportunity to extend the contract could open doors for additional service providers. The procurement aims to uphold patient choice with a focus on service delivery that lacks a realistic alternative, thereby benefiting businesses capable of providing niche health service solutions.